| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
βARK1 Inhibitor Inhibitor | 24269-96-3 | sc-221268 | 5 mg | $254.00 | 4 | |
βARK1 Inhibitor functions as a selective modulator of G protein-coupled receptor kinase 2 (GRK2), influencing receptor desensitization and signaling pathways. Its unique binding affinity allows it to stabilize specific conformations of GRK2, thereby altering its interaction with substrates. This compound exhibits distinct kinetic properties, promoting a nuanced regulation of downstream signaling cascades, which can lead to varied cellular responses. Its structural characteristics facilitate targeted engagement with GRK2, enhancing its role in cellular signaling dynamics. | ||||||
Paroxetine | 61869-08-7 | sc-507527 | 1 g | $180.00 | ||
Paroxetine is an antidepressant that might inhibit GRK2 by interfering with its activity, potentially modulating G protein-coupled receptor (GPCR) signaling. | ||||||
Compound 101 | 161125-36-6 | sc-507528 | 5 mg | $108.00 | ||
Compound 101 is a potential GRK2 inhibitor that might impact its kinase activity, potentially affecting GPCR signaling and cellular responses. | ||||||
(-)-trans-4-[4-(4′-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite) | 112058-90-9 | sc-213088 | 5 mg | $380.00 | ||
A metabolite of paroxetine, the antidepressant, that might also inhibit GRK2 and modulate GPCR signaling pathways. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a beta-blocker that might inhibit GRK2 by modulating GPCR signaling pathways and cellular responses. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Pindolol is a non-selective beta-blocker that might inhibit GRK2 by affecting GPCR signaling pathways and cellular responses. | ||||||